Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Frequency of Home Phenylalanine Measurements on Metabolic Control in a Population of Patients With Classic Phenylketonuria (FreqPHEncy) - a Single-center Randomized Cross-over Clinical Trial

NCT07825883 is registered in ClinicalTrials.gov with Michał Kania as lead sponsor.

NCT NCT07825883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07825883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Frequency of Home Phenylalanine Measurements on Metabolic Control in a Population of Patients With Classic Phenylketonuria (FreqPHEncy) - a Single-center Randomized Cross-over Clinical Trial
Lead sponsor
Michał Kania
Phase
Not applicable
Overall status
Recruiting
Start date
September 11, 2026
Completion date
December 31, 2028
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

phenylketonuria (pku)